Cardiovascular disease in patients with inflammatory rheumatic disease is associated with up-regulation of markers of inflammation in cardiac microvessels and cardiomyocytes

Arthritis and Rheumatism

Volumn 62, Issue 3, 2010, Pages 667-673

  Grundtman, Cecilia ^a,b   Hollan, Ivana ^c,d   Førre, Øystein T ^e   Saatvedt, Kjell ^d   Mikkelsen, Knut ^c   Lundberg, Ingrid E ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c Hospital for Rheumatic Diseases   (Norway)

^d Feiring Heart Clinic   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN; CD3 ANTIGEN; CD31 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CELL ADHESION MOLECULE; CHLORDANE; CYTOKINE; HLA ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; FEMALE; HEART MUSCLE; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; MALE; MONONUCLEAR CELL; MYOCARDITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATIC DISEASE; SKELETAL MUSCLE;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CELL ADHESION MOLECULES; CYTOKINES; FEMALE; HLA ANTIGENS; HUMANS; INFLAMMATION; MALE; MICROVESSELS; MUSCLE, SKELETAL; MYOCYTES, CARDIAC; RHEUMATIC DISEASES; UP-REGULATION;

EID: 77649158996     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27264     Document Type: Article

References (15)

1. Van Doornum S, McColl G, Wicks IP. Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 2002;46:862-73.
2. Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 2002;359:1173-7.
3. Del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001;44:2737-45.
4. Hollan I, Scott H, Saatvedt K, Prayson R, Mikkelsen K, Nossent HC, et al. Inflammatory rheumatic disease and smoking are predictors of aortic inflammation: a controlled study of biopsy specimens obtained at coronary artery surgery. Arthritis Rheum 2007;56:2072-9.
5. Ulfgren AK, Grundtman C, Borg K, Alexanderson H, Andersson U, Harris HE, et al. Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids. Arthritis Rheum 2004;50:1586-94.
6. Collins T, Cybulsky MI. NF-κB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest 2001;107:255-64.
7. Bely M, Apathy A, Beke-Martos E. Cardiac changes in rheumatoid arthritis. Acta Morphol Hung 1992;40:149-86.
8. Recio-Mayoral A, Mason JC, Kaski JC, Rubens MB, Harari OA, Camici PG. Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease. Eur Heart J 2009;30:1837-43.
9. Gabriel SE. Cardiovascular morbidity and mortality in rheumatoid arthritis. Am J Med 2008;121(10 Suppl 1):S9-S14.
10. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 2001;103:2055-9.
11. Doyama K, Fujiwara H, Fukumoto M, Tanaka M, Fujiwara Y, Oda T, et al. Tumour necrosis factor is expressed in cardiac tissues of patients with heart failure. Int J Cardiol 1996;54:217-25.
12. Francis SE, Holden H, Holt CM, Duff GW. Interleukin-1 in myocardium and coronary arteries of patients with dilated cardiomyopathy. J Mol Cell Cardiol 1998;30:215-23.
13. Bryant D, Becker L, Richardson J, Shelton J, Franco F, Peshock R, et al. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α. Circulation 1998;97:1375-81.
14. Caforio AL, Stewart JT, Bonifacio E, Burke M, Davies MJ, McKenna WJ, et al. Inappropriate major histocompatibility complex expression on cardiac tissue in dilated cardiomyopathy: relevance for autoimmunity? J Autoimmun 1990;3:187-200.
15. Van Halm VP, Nurmohamed MT, Twisk JW, Dijkmans BA, Voskuyl AE. Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. Arthritis Res Ther 2006;8:R151.